| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2018 | ELV Elevance Health, Inc. | Gallina John E | EVP &Chief Financial Officer | Sell | 24,576 | $229.81 | $5,647,898.44 | -28.6% | |
| Mar 5, 2018 | CCRN Cross Country Healthcare Inc | Cash W Larry | Director | Buy | 5,000 | $11.23 | $56,150.00 | +4.6% | |
| Mar 5, 2018 | ELV Elevance Health, Inc. | Swedish Joseph | Executive Chairman | Sell | 27,846 | $231.12 | $6,435,755.96 | -7.2% | |
| Mar 5, 2018 | ADUS Addus Homecare Corp | Poff Brian63 | Chief Financial Officer | Sell | 1,240 | $34.06 | $42,234.40 | -5.0% | |
| Mar 5, 2018 | ADUS Addus Homecare Corp | Allison R Dirk65 | Chief Executive Officer | Sell | 911 | $34.04 | $31,010.44 | -2.1% | |
| Mar 5, 2018 | ADUS Addus Homecare Corp | Zoccoli James | Chief Information Officer | Sell | 239 | $34.03 | $8,133.17 | -1.0% | |
| Mar 5, 2018 | DGX Quest Diagnostics Inc | Davis J. E. | EVP, General Diagnostics | Sell | 5,122 | $101.00 | $517,322.00 | -12.1% | |
| Mar 5, 2018 | ADUS Addus Homecare Corp | Anderson Darby57 | Evp/ Chief Development Officer | Sell | 526 | $34.02 | $17,894.52 | -1.7% | |
| Mar 5, 2018 | DGX Quest Diagnostics Inc | Prevoznik Michael E52 | SVP &General Counsel | Sell | 4,128 | $101.00 | $416,928.00 | -9.4% | |
| Mar 5, 2018 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sell | 5,556 | $101.00 | $561,156.00 | -7.6% | |
| Mar 1, 2018 | BKD Brookdale Senior Living Inc. | Seward James R | Director | Buy | 5,000 | $6.68 | $33,400.00 | +5.1% | |
| Mar 1, 2018 | ADUS Addus Homecare Corp | Anderson Darby57 | Evp/ Chief Development Officer | Sell | 1,014 | $34.25 | $34,729.50 | -3.5% | |
| Mar 1, 2018 | CHE Chemed Corp | McNamara Kevin J57 | President And CEO | Sell | 6,000 | $258.00 | $1,547,970.00 | -2.1% | |
| Mar 1, 2018 | MCK McKesson Corp | Lampert Erin M | SVP &Controller | Sell | 1,413 | $149.38 | $211,071.11 | -100% | |
| Mar 1, 2018 | MOH Molina Healthcare, Inc. | Romney Ronna60 | Director | Sell | 250 | $72.17 | $18,042.50 | -1.1% | |
| Mar 1, 2018 | ACHC Acadia Healthcare Company, Inc. | Goldberg Randall P | VP Of Business Development | Sell | 960 | $38.47 | $36,927.39 | -7.1% | |
| Mar 1, 2018 | UNH Unitedhealth Group Inc | Burke Richard T | Director | Sell | 10,400 | $229.87 | $2,390,616.00 | -0.3% | |
| Feb 28, 2018 | HUM Humana Inc | Margulis Heidi S | Chief Corp. Affairs Officer | Sell | 3,727 | $275.17 | $1,025,574.24 | -32.1% | |
| Feb 28, 2018 | BKD Brookdale Senior Living Inc. | Bumstead Frank M | Director | Buy | 20,000 | $6.70 | $134,000.00 | +14.5% | |
| Feb 28, 2018 | HUM Humana Inc | Fleming William Kevin48 | Seg President, Healthcare Svcs | Sell | 1,073 | $275.35 | $295,450.12 | -11.6% | |
| Feb 28, 2018 | DGX Quest Diagnostics Inc | Davis J. E. | EVP, General Diagnostics | Sell | 1,798 | $104.42 | $187,748.52 | -2.4% | |
| Feb 28, 2018 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sell | 1,820 | $104.38 | $189,971.08 | -1.3% | |
| Feb 28, 2018 | DGX Quest Diagnostics Inc | Prevoznik Michael E52 | SVP &General Counsel | Sell | 1,423 | $104.41 | $148,575.74 | -1.7% | |
| Feb 27, 2018 | BKD Brookdale Senior Living Inc. | Seward James R | Director | Buy | 15,000 | $6.98 | $104,698.50 | +18.2% | |
| Feb 27, 2018 | ENSG Ensign Group, Inc | Nackel John G. | Director | Sell | 7,000 | $27.90 | $195,300.00 | -7.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.